Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia | Canada Hyperbarics Skip to main content
Clinical Trial Ann N Y Acad Sci 2001 Canadian

Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia

Auer R — Ann N Y Acad Sci, 2001

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This paper emphasized five physiological strategies, hypothermia, insulin, arterial hyperoxemia, blood pressure control, and magnesium, that could help reduce brain damage after an ischaemic stroke.

What They Found

Researchers found that hypothermia protected against neuronal damage and infarction in both focal and global ischaemia. Insulin helped by normalizing glucose levels in focal ischaemia, while controlled arterial hyperoxemia experimentally reduced infarct size. Raising blood pressure improved blood flow and reduced stroke size, and magnesium was identified as a safe NMDA antagonist.

Canadian Relevance

This study was authored by a Canadian researcher. While brain ischaemia is not a Health Canada-recognised indication for hyperbaric oxygen therapy, the paper discusses strategies, including arterial hyperoxemia, relevant to neurological protection.

Study Limitations

This paper primarily reviewed and emphasized existing physiological measures and experimental findings rather than presenting new clinical trial data, and the abstract itself is an overview of potential strategies.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Trial
Category Neurological
Source Pubmed
PubMed ID 11462780
Year Published 2001
Journal Ann N Y Acad Sci
MeSH Terms Animals; Blood Pressure; Brain Ischemia; Humans; Hyperbaric Oxygenation; Hypoglycemic Agents; Hypothermia, Induced; Insulin; Magnesium

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology